军事知识服务平台
初诊时伴发髓外病变的多发性骨髓瘤预后因素分析
Clinical features and outcome analyses of newly-diagnosed multiple myeloma with extramedullary involvements
摘要 目的 探讨初诊时伴有髓外病变的多发性骨髓瘤(MM)患者的临床特点及影响预后的因素.方法 回顾性分析2000年1月到2011年10月收治的46例初诊时伴髓外病变的MM患者(A组)的临床和病理特点、治疗效果、生存情况和影响预后的因素,以同时期收治的53例初诊时不伴发髓外病变的MM患者(B组)为对照.结果 A组与B组比较,β2微球蛋白(β2-MG)水平较高、溶骨性病变≥3处者多见(P =0.045、0.039).A组髓外病变最常见的受累部位依次为软组织、椎管内、肺部、胸膜、颅内及淋巴结.中位随访28(2 ~88)个月.A组治疗总有效率低于B组[58.5% (24/41)比78.8% (41/52),P=0.042];预计中位总生存期低于B组(42.6个月比53.9个月,P=0.009).单因素分析显示初诊时溶骨性病变≥3处、血红蛋白≤110g/L、β2-MG≥5.5 mg/L、白蛋白≤30/L为A组患者的不良预后因素(均P< 0.05);Cox回归多因素分析显示,溶骨性病变≥3处(OR=2.327,95% CI:1.282 ~4.224)及β2-MG≥5.5 mg/L( OR =2.677,95% CI:1.092 ~6.566)为影响A组患者总生存的独立不良预后因素.结论 初诊的MM患者可多处并发髓外病变,这类患者总体疗效欠佳,预后不良,溶骨性病变≥3处及β2-MG≥5.5 mg/L为独立的不良预后因素.
Abstract:
Objective To explore the clinical features and prognostic factors of newly-diagnosed multiple myeloma ( MM ) with extramedullary ( EM ) involvements.Methods The clinical features,efficacies,survival rates and prognostic factors were retrospectively analyzed in 46 MM patients with EM (group A) from January 2000 to October 2011.And another 53 MM patients without EM (group B) were selected as the controls.Results The median age of Group A was 58 years.Compared with group B,the incidence of EM was associated with a higher level of β2-microglobulin ( β2-MG ) and extensive bone disease.The most common location of EM was soft tissues.And the total effective rates of groups A and B were 58.5% (24/41) and 78.8% (41/52) respectively.The difference was statistically significant ( P =0.042).The median follow-up time was 28 (2 -88) months.The estimated overall survival (OS) of the patients with EM was significantly shorter than those without EM (42.6 vs 53.9 months,P =0.009).Logrank univariate analysis showed that the number of osteolytic lesions ≥3,β2-MG≥5.5 mg/L,hemoglobin ≤110 g/L and albunin ≤30 g/L were poor prognostic factors in MM patients with EM. Multivariate analysis with Cox model showed only the number of osteolytic lesions ≥ 3 ( OR =2.327,95 % CI:1.282 - 4.224 ) and β2-MG≥ 5.5 mg/L ( OR =2.677,95% CI:1.092 - 6.566 ) were statistically significant.Conclusions Multiple EM lesions may be involved in MM patients.For the patients with EM,the response to conventional chemotherapy is poor and the prognosis is unfavorable,especially for those with a high level of β2-MG or the number of osteolvtic lesions ≥ 3.
Author: ZHANG Yi-zhuo ZHI Ya-qin WANG Ya-fei YU Yong ZHAO Zhi-gang WANG Xiao-fang ZHAI Qiong-li SUN Bao-cun
作者单位: 300060,天津市肿瘤防治中心重点实验室天津医科大学附属肿瘤医院血液科 300060,天津市肿瘤防治中心重点实验室天津医科大学附属肿瘤医院病理科
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2012, 92(34)
分类号: R4
机标分类号: R733.3 R551.2 R681
在线出版日期: 2012年12月5日